By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Personalized Medicine have been published. According to news reporting originating from Beijing, People's Republic of China, by NewsRx correspondents, research stated, "In the medical imaging field, molecular imaging is a rapidly developing discipline and forms many imaging modalities, providing us effective tools to visualize, characterize, and measure molecular and cellular mechanisms in complex biological processes of living organisms, which can deepen our understanding of biology and accelerate preclinical research including cancer study and medicine discovery. Among many molecular imaging modalities, although the penetration depth of optical imaging and the approved optical probes used for clinics are limited, it has evolved considerably and has seen spectacular advances in basic biomedical research and new drug development."
Our news editors obtained a quote from the research from the Institute of Automation, "With the completion of human genome sequencing and the emergence of personalized medicine, the specific drug should be matched to not only the right disease but also to the right person, and optical molecular imaging should serve as a strong adjunct to develop personalized medicine by finding the optimal drug based on an individual's proteome and genome. In this process, the computational methodology and imaging system as well as the biomedical application regarding optical molecular imaging will play a crucial role. This review will focus on recent typical translational studies of optical molecular imaging for personalized medicine followed by a concise introduction."
According to the news editors, the research concluded: "Finally, the current challenges and the future development of optical molecular imaging are given according to the understanding of the authors, and the review is then concluded."
For more information on this research see: Translational research of optical molecular imaging for personalized medicine. Current Molecular Medicine, 2013;13(10):1579-90. (Bentham Science Publishers - www.benthamscience.com; Current Molecular Medicine - www.benthamscience.com/cmm/index.htm)
The news editors report that additional information may be obtained by contacting C. Qin, Key Laboratory of Molecular Imaging of Chinese Academy of Sciences, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, People's Taiwan. Additional authors for this research include X. Ma and J. Tian (see also Personalized Medicine).
Keywords for this news article include: Asia, Beijing, Nanotechnology, Molecular Imaging, Emerging Technologies, Personalized Medicine, People's Republic of China.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC